The Journal of Practical Medicine ›› 2021, Vol. 37 ›› Issue (9): 1122-1126.doi: 10.3969/j.issn.1006⁃5725.2021.09.005

• Basic Research • Previous Articles     Next Articles

The effects of ERK1/2 inhibitors on the airway hypersecretion of mucin 5ac(Muc5ac)in COPD mice

QIN Yingjiao,ZHOU Xiangdong,ZHONG Youqing,WANG Jie,LIU Feng.   

  1. Department of Respiratory Medicine,the First Affiliated Hospital of Hainan Medical College,Haikou 570102,China

  • Online:2021-05-10 Published:2021-05-10
  • Contact: ZHOU Xiang Dong E⁃mail:zxd999@263.net

Abstract:

Objective To explore the mechanism of extracellular signal ⁃ regulated protein kinase 1/2 (ERK1/2)inhibitor U0126 on airway hypersecretion of mucin 5ac(muc5ac)protein in chronic obstructive pulmo⁃ nary disease(COPD)mice. Methods The pulmonary function indexes,interleukin 4(IL ⁃4)and interferon γ (IFN⁃γ)levels of each group of mice after 7 days of intervention with different drugs were detected.HE staining to observe the pathological changes of lung tissue. RT⁃qPCR was used to detect the expression levels of muc5ac and ERK1/2 mRNA in lung tissues. Western blotting was used to detect the expression levels of muc5ac,ERK1/2,and p⁃ERK1/2 proteins in lung tissue. Results Compared with the model group,the levels of FEV0.3,FVC,FEV0.3/ FVC and IL⁃4 in the inhibitory drug group and the western drug group were increased,whereas the levelsof IFN⁃γ, muc5acmRNA,and the protein expression levels of muc5ac and p⁃ERK1/2 were decreased(P < 0.05). The patho⁃ logical changes of lung tissue improved. Conclusion ERK1/2 inhibitors can reduce the expression of muc5ac by inhibiting the ERK1/2 signaling pathway and improve the symptoms of COPD.

Key words:

extracellular signal ? regulated protein kinase 1/2, chronic obstructive pulmonary disease, mouse, airway, mucin 5ac